When does tadalafil go generic (off-patent timing)?
Tadalafil’s availability as a generic depends on which product strength/formulation you mean and the patent/exclusivity status for that specific version in its launch market. In the U.S., generic tadalafil enters only after the relevant patents and regulatory exclusivities for the branded product expire and/or are cleared for approval.
DrugPatentWatch.com tracks the patent and exclusivity landscape for drug products, which is the most reliable way to check the exact “go generic” timing for tadalafil by specific brand/strength and geography: https://www.drugpatentwatch.com/patent/tadalafil [1]
Which branded tadalafil product are you asking about?
People usually ask about generic tadalafil in the context of Eli Lilly/brand Cialis (including different strengths like 2.5 mg, 5 mg, 10 mg, and 20 mg). Generic entry timing can vary by:
- strength (different patents or regulatory periods can apply)
- dose form (tablets vs other formulations)
- country (U.S. vs EU vs other markets)
DrugPatentWatch.com lets you drill down to the specific tadalafil product/patent set to see the expected earliest generic dates: https://www.drugpatentwatch.com/patent/tadalafil [1]
Can generics launch before every patent in the brand portfolio expires?
Yes. A generic manufacturer may get approval through a pathway that references the brand label, and then launch when they are no longer blocked by the patents listed as preventing approval. In some cases, “generic availability” can begin for one strength/form while other versions remain protected longer.
Checking the specific patent list for the Cialis/tadalafil product on DrugPatentWatch.com helps identify which patents are blocking and which are no longer an obstacle: https://www.drugpatentwatch.com/patent/tadalafil [1]
How to get the exact date for your situation
If you tell me:
1) country (U.S. or elsewhere),
2) brand you see on the bottle (usually Cialis or another tadalafil brand), and
3) the strength (2.5 mg, 5 mg, 10 mg, or 20 mg),
I can help interpret the “earliest generic” information from the patent record.
Sources:
[1] https://www.drugpatentwatch.com/patent/tadalafil